AI Verdict
MITK has stronger fundamentals based on our AI analysis.
MITK vs MIST Fundamental Comparison
| Metric | MITK | MIST |
|---|---|---|
| Revenue | $44.2M | N/A |
| Net Income | $2.8M | $-63.1M |
| Net Margin | 6.3% | N/A |
| ROE | 1.2% | -151.0% |
| ROA | 0.6% | -55.5% |
| Current Ratio | 1.18x | 8.01x |
| Debt/Equity | 0.02x | 1.37x |
| EPS | $0.06 | $-0.75 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MITK vs MIST: Frequently Asked Questions
Is MITK or MIST a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MITK has stronger fundamentals. MITK is rated HOLD (62% confidence) while MIST is rated STRONG SELL (92% confidence). This is not investment advice.
How does MITK compare to MIST fundamentally?
MITEK SYSTEMS INC has ROE of 1.2% vs Milestone Pharmaceuticals Inc.'s -151.0%. Net margins are 6.3% vs N/A respectively.
Which stock pays higher dividends, MITK or MIST?
MITK has a dividend yield of N/A or no dividend while MIST has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MITK or MIST for long term?
For long-term investing, consider that MITK has HOLD rating with 62% confidence, while MIST has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MITK vs MIST?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MITK vs MIST, the AI consensus favors MITK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.